Abstract:With the continuous development of imaging technology and nanotechnology, it is expected to further make in‐depth study on tumor‐associated bacteria and develop new bacterial imaging methods for tumor diagnosis. Some bacteria, such as Escherichia coli (E. coli) and Salmonella typhimurium (S. typhimurium), have an inherent ability to locate solid tumours, making them a versatile platform that can be combined with other tools to improve the tumour diagnosis and treatment. In anti‐cancer therapy, bacteria function by carrying drugs directly or expressing exogenous therapeutic genes. The application of bacterial imaging in tumour diagnosis, a novel and promising research area, can indeed provide dynamic and real‐time monitoring in both pre‐treatment assessment and post‐treatment detection. Different imaging techniques, including optical technology, acoustic imaging, magnetic resonance imaging (MRI) and nuclear medicine imaging, allow us to observe and track tumour‐associated bacteria. Optical imaging, including bioluminescence and fluorescence, provides high‐sensitivity and high‐resolution imaging. Acoustic imaging is a real‐time and non‐invasive imaging technique with good penetration depth and spatial resolution. MRI provides high spatial resolution and radiation‐free imaging. Nuclear medicine imaging, including positron emission tomography (PET) and single photon emission computed tomography (SPECT) can provide information on the distribution and dynamics of bacterial population. Moreover, strategies of synthetic biology modification and nanomaterial engineering modification can improve the viability and localization ability of bacteria while maintaining their autonomy and vitality, thus aiding the visualization of gut bacteria. However, there are some challenges, such as the relatively low bacterial abundance and heterogeneously distribution within the tumour, the high dimensionality of spatial datasets and the limitations of imaging labeling tools. In summary, with the continuous development of imaging technology and nanotechnology, it is expected to further make in‐depth study on tumour‐associated bacteria and develop new bacterial imaging methods for tumour diagnosis.

Attenuated Salmonella typhimurium-mediated tumour targeting imaging based on peptides.

Biomimetic Metallacage Nanoparticles with Aggregation-Induced Emission for NIR-II Fluorescence Imaging-Guided Synergistic Immuno-Phototherapy of Tumors

Engineering of Bacteria for the Visualization of Targeted Delivery of A Cytolytic Anticancer Agent

Targeted Cancer Therapy Using Engineered Salmonella typhimurium.

Cancer-cell killing by engineered Salmonella imaged by multiphoton tomography in live mice.

Attenuated Salmonella Typhimurium with Truncated LPS and Outer Membrane-Displayed RGD Peptide for Cancer Therapy.

Nanoparticles Conjugated with Bacteria Targeting Tumors for Precision Imaging and Therapy.

Radiotherapy Combined with an Engineered Salmonella Typhimurium Inhibits Tumor Growth in a Mouse Model of Colon Cancer.

Oral Delivery of Tumor‐targeting Salmonella for Cancer Therapy in Murine Tumor Models

Optimized Attenuated Salmonella Typhimurium Suppressed Tumor Growth and Improved Survival in Mice

New Approach of Biotherapy for Cancer-Application of Attenuated Salmonella Typhimurium

Programmable Bacteria with Dynamic Virulence Modulation System for Precision Antitumor Immunity

Genetically engineered probiotics for an optical imaging-guided tumor photothermal therapy/immunotherapy

Targeting Hypoxia for Sensitization of Tumors to Apoptosis Enhancement Through Supramolecular Biohybrid Bacteria

Excessive autophagy-inducing and highly penetrable biomineralized bacteria for multimodal imaging-guided and mild hyperthermia-enhanced immunogenic cell death

Tumor Pre-Targeting System Using Streptavidin-Expressing Bacteria

Dual drugs decorated bacteria irradiate deep hypoxic tumor and arouse strong immune responses

Bacterial imaging in tumour diagnosis

Targeted cancer immunotherapy with genetically engineered oncolytic Salmonella typhimurium.

Endostatin Gene Therapy Delivered by Attenuated Salmonellatyphimurium in Murine Tumor Models

Tumor-Targeting Salmonella Typhimurium A1-R Arrests Growth Of Breast-Cancer Brain Metastasis